Skip to main content
. Author manuscript; available in PMC: 2014 Feb 15.
Published in final edited form as: Clin Cancer Res. 2012 Dec 18;19(4):855–864. doi: 10.1158/1078-0432.CCR-12-2746

Figure 3.

Figure 3

Effects of radiation, cetuximab, and cisplatin in three tumorgrafts: UW-SCC6 (A), UW-SCC14N (B), and UW-SCC22 (C). Treatments, started when subcutaneously growing tumors reached a volume of approximately 200 mm3, were administered twice weekly for two weeks as described in the methods. Growth curves plotting the mean (+/− SEM) tumor volume over time are shown. For each group, n=8–10 mice with dual tumors began treatment. *p<0.01, #p=not significant. D) Early passage cell strains developed from UW-SCC24 and UW-SCC14N were assessed for proliferative potential in the presence of indicated drugs. Cell number was estimated by CCK8 assay and standardized to the maximum relative value of vehicle control.

HHS Vulnerability Disclosure